Dr Pepper Snapple sees FY14 core EPS $3.38-$3.46, consensus $3.41 Sees FY14 reported net sales flat to up 1%, consensus $6.03B. Packaging and ingredient costs, including LIFO impacts, are expected to decrease COGS by 2% on a constant volume/mix basis. The company expects its core tax rate to be approximately 35.5%. The company continues to expect capital spending to be approximately 3% of net sales. The company expects to repurchase $375M-$400M of its common stock.